focus -WSS

focus

author：entertainment 2025-08-27 18:59:51 - browse：2

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： The mammogram wars are not over

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Ford recalls 870K F

Timeline: Special counsel's probe into Trump's handling of classified documents

Stoke drug shows lower activity against childhood epilepsy

6 phony surgeries that take placebo to the extreme

Wikipedia

focus

explore

Continuity nursing helped my family in our darkest PICU moments

Marc Tessier

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

DIEP, the 'gold standard' of breast reconstruction, is under threat

Will biotech layoffs continue through 2023?

In Memoriam: Notable people who died in 2023

Why palliative psychiatry is worth discussing

Medical leaders decry Supreme Court decision on affirmative action

Alabama frozen embryo ruling has major implications for IVF clinics

hotspot

He's a Nobel laureate. Critics say he was misleading on Covid

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

As the dark side of IVF slowly comes into focus, even more transparency is needed

Dario to buy mental health app maker Twill in cash and stock deal

PBM reform efforts get punted in Congress

Alexander Hamilton and the argument for universal insurance

explore

explore

knowledge

hotspot